Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
Main Authors: | Schirosi, Laura, Strippoli, Sabino, Gaudio, Francesca, Graziano, Giusi, Popescu, Ondina, Guida, Michele, Simone, Giovanni, Mangia, Anita |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116153/ |
Similar Items
-
The role of BRAF V600 mutation in melanoma
by: Ascierto, Paolo A, et al.
Published: (2012) -
Amelanotic melanoma presenting with plasmacytoid morphology and BRAF V600 mutation
by: Linda Kocovski, et al.
Published: (2015-06-01) -
Amelanotic Melanoma Presenting with Plasmacytoid Morphology and BRAF V600 Mutation
by: Kocovski, Linda, et al.
Published: (2015) -
Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation
by: Garrisi, Vito Michele, et al.
Published: (2014) -
Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma
by: Fisher, Rosalie, et al.
Published: (2012)